Mechanisms of sinoatrial node dysfunction in a canine model of pacing-induced atrial fibrillation

Heart Rhythm. 2010 Jan;7(1):88-95. doi: 10.1016/j.hrthm.2009.09.018. Epub 2009 Sep 16.

Abstract

Background: The mechanism of sinoatrial node (SAN) dysfunction in atrial fibrillation (AF) is unclear.

Objective: The purpose of this study was to test the hypothesis that defective spontaneous sarcoplasmic reticulum (SR) Ca(2+) release (Ca(2+) clock) is in part responsible for SAN dysfunction in AF.

Methods: Arrhythmic events and SAN function were evaluated in pacing-induced AF dogs (n = 7) and in normal dogs (n = 19) with simultaneous intracellular calcium (Ca(i)) and membrane potential recording.

Results: AF dogs had frequent sinus pauses during Holter monitoring. Isolated right atrium (RA) from AF dogs showed slower heart rate (P = .001), longer SAN recovery time (P = .001), and longer sinoatrial conduction time (P = .003) than normal. In normal RAs, isoproterenol 0.3 and 1 mumol/L increased heart rate by 96% and 105%, respectively. In contrast, in RAs from AF dogs, isoproterenol increased heart rate by only 60% and 72%, respectively. Isoproterenol induced late diastolic Ca(i) elevation (LDCAE) at superior SAN in all 19 normal RAs but in only 3 of 7 AF RAs (P = .002). In AF RAs without LDCAE (n = 4), heart rate increased by the acceleration of ectopic foci. Caffeine (20 mmol/L) injection increased heart rate with LDCAE in all 6 normal RAs but did not result in LDCAE in any of the 5 AF RAs (P = .002). Type 2 ryanodine receptor (RyR2) in the superior SAN of AF dogs was decreased to 33% of normal (P = .02).

Conclusion: SAN dysfunction in AF is associated with Ca(2+) clock malfunction, characterized by unresponsiveness to isoproterenol and caffeine and down-regulation of RyR2 in SAN.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Atrial Fibrillation / classification
  • Atrial Fibrillation / etiology
  • Atrial Fibrillation / physiopathology*
  • Caffeine / pharmacology
  • Calcium / metabolism*
  • Calcium Channels, L-Type
  • Calcium-Binding Proteins
  • Cardiac Pacing, Artificial / adverse effects*
  • Central Nervous System Stimulants / pharmacology
  • Disease Models, Animal
  • Dogs
  • Down-Regulation
  • Heart Rate / drug effects
  • Isoproterenol / pharmacology
  • Risk Factors
  • Ryanodine Receptor Calcium Release Channel / drug effects
  • Ryanodine Receptor Calcium Release Channel / metabolism
  • Sarcoplasmic Reticulum / drug effects
  • Sarcoplasmic Reticulum / metabolism*
  • Sinoatrial Node / physiopathology*

Substances

  • Adrenergic beta-Agonists
  • Calcium Channels, L-Type
  • Calcium-Binding Proteins
  • Central Nervous System Stimulants
  • Ryanodine Receptor Calcium Release Channel
  • Caffeine
  • Isoproterenol
  • Calcium